508 related articles for article (PubMed ID: 8204469)
21. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
Fine JD
J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
[TBL] [Abstract][Full Text] [Related]
22. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
[TBL] [Abstract][Full Text] [Related]
23. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
24. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
25. Floor-pattern salt-split skin cannot distinguish bullous pemphigoid from epidermolysis bullosa acquisita. Use of toad skin.
Pang BK; Lee YS; Ratnam KV
Arch Dermatol; 1993 Jun; 129(6):744-6. PubMed ID: 8507077
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence overlay antigen mapping using laser scanning confocal microscopy differentiates linear IgA bullous dermatosis from epidermolysis bullosa acquisita mediated by IgA.
Wozniak K; Hashimoto T; Ishii N; Koga H; Huczek M; Kowalewski C
Br J Dermatol; 2013 Mar; 168(3):634-8. PubMed ID: 22924407
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of an avidin-biotin-peroxidase method with a monoclonal antibody to type IV collagen in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
Bowszyc-Dmochowska M; Hashimoto T; Dmochowski M; Nishikawa T
J Dermatol; 1997 Apr; 24(4):217-22. PubMed ID: 9164061
[TBL] [Abstract][Full Text] [Related]
28. Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid.
Bhol K; Mohimen A; Neumann R; Yunis J; Foster S; Yunis EJ; Ahmed AR
Curr Eye Res; 1996 May; 15(5):521-32. PubMed ID: 8670753
[TBL] [Abstract][Full Text] [Related]
29. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid.
Murakami H; Nishioka S; Setterfield J; Bhogal BS; Black MM; Zillikens D; Yancey KB; Balding SD; Giudice GJ; Diaz LA; Nishikawa T; Kiyokawa C; Hashimoto T
J Dermatol Sci; 1998 May; 17(1):39-44. PubMed ID: 9651827
[TBL] [Abstract][Full Text] [Related]
30. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
[TBL] [Abstract][Full Text] [Related]
31. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
32. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
Woźniak K; Kowalewski C
J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
[TBL] [Abstract][Full Text] [Related]
33. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.
Kirtschig G; Marinkovich MP; Burgeson RE; Yancey KB
J Invest Dermatol; 1995 Oct; 105(4):543-8. PubMed ID: 7561156
[TBL] [Abstract][Full Text] [Related]
34. Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid.
Smoller BR; Woodley DT
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):674-8. PubMed ID: 1430385
[TBL] [Abstract][Full Text] [Related]
35. [Inflammatory type of epidermolysis bullosa acquisita].
Zillikens D; Erhard H; Prost C; Hashimoto T; Nishikawa T; Bröcker EB
Hautarzt; 1994 Mar; 45(3):166-70. PubMed ID: 8175345
[TBL] [Abstract][Full Text] [Related]
36. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
[TBL] [Abstract][Full Text] [Related]
37. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
Jenkins RE; Rodenas J; Bhogal BS; Black MM
Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
[TBL] [Abstract][Full Text] [Related]
38. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.
Wieme N; Lambert J; Moerman M; Geerts ML; Temmerman L; Naeyaert JM
Dermatology; 1999; 198(3):310-3. PubMed ID: 10393462
[TBL] [Abstract][Full Text] [Related]
39. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
[TBL] [Abstract][Full Text] [Related]
40. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
